Scrip RSS Feedhttps://insights.citeline.comThe Latest News & Analysis from ScripWed, 11 Nov 2026 11:24:55 +0000en1hourly1 https://insights.citeline.com/scrip/r-and-d/clinical-trials/beam-eyes-risto-cel-bla-as-early-as-year-end-after-positive-sickle-cell-data-5VPMJND6R5ETPPU5GV22ZYYTLQ/<![CDATA[Beam Eyes Risto-Cel BLA As Early As Year-End After Positive Sickle Cell Data]]>premium

      
]]> https://feeds.feedblitz.com/~/972815960/0/scrip~Beam-Eyes-RistoCel-BLA-As-Early-As-YearEnd-After-Positive-Sickle-Cell-Data/https://insights.citeline.com/scrip/r-and-d/clinical-trials/beam-eyes-risto-cel-bla-as-early-as-year-end-after-positive-sickle-cell-data-5VPMJND6R5ETPPU5GV22ZYYTLQ/
      
]]> Wed, 11 Nov 2026 11:13:07 +0000 https://insights.citeline.com/scrip/partnered-content/video-interview-the-future-of-cdmos-integrated-development-and-complex-modalities-ZBIHHGNG4ZACXMAXP5ZUISXWXQ/<![CDATA[Video Interview: The Future of CDMOs: Integrated Development and Complex Modalities]]>free

      
]]> https://feeds.feedblitz.com/~/972748583/0/scrip~Video-Interview-The-Future-of-CDMOs-Integrated-Development-and-Complex-Modalities/https://insights.citeline.com/scrip/partnered-content/video-interview-the-future-of-cdmos-integrated-development-and-complex-modalities-ZBIHHGNG4ZACXMAXP5ZUISXWXQ/
      
]]> Tue, 10 Nov 2026 09:11:16 +0000 https://insights.citeline.com/scrip/therapeutic-category/immunological/acr-2026-can-immuneoncos-bispecific-take-on-roches-gazyva-in-sle-BCGLZNZ735FZ7G6WDDH7DCOARY/<![CDATA[ACR 2026: Can ImmuneOnco‘s Bispecific Take On Roche’s Gazyva In SLE?]]>premium

      
]]> https://feeds.feedblitz.com/~/972809495/0/scrip~ACR-Can-ImmuneOnco%e2%80%98s-Bispecific-Take-On-Roche%e2%80%99s-Gazyva-In-SLE/https://insights.citeline.com/scrip/therapeutic-category/immunological/acr-2026-can-immuneoncos-bispecific-take-on-roches-gazyva-in-sle-BCGLZNZ735FZ7G6WDDH7DCOARY/
      
]]> Wed, 11 Nov 2026 09:08:42 +0000 https://insights.citeline.com/scrip/leadership/interviews/divamics-targeting-differentiation-in-application-of-ai-to-drug-design-63XTLQRZQVCMJIFA4HAOIUEMD4/<![CDATA[Divamics Targeting Differentiation In Application Of AI To Drug Design ]]>premium

      
]]> https://feeds.feedblitz.com/~/972804641/0/scrip~Divamics-Targeting-Differentiation-In-Application-Of-AI-To-Drug-Design/https://insights.citeline.com/scrip/leadership/interviews/divamics-targeting-differentiation-in-application-of-ai-to-drug-design-63XTLQRZQVCMJIFA4HAOIUEMD4/
      
]]> Wed, 11 Nov 2026 07:27:16 +0000 https://insights.citeline.com/scrip/therapeutic-category/alimentary-metabolic/obesity/boehringer-ready-to-file-survodutide-but-at-what-threat-to-obesity-leaders-S2CFSJ4A2VDKVCMK5DPPGMYALA/<![CDATA[Boehringer Ready To File Survodutide But At What Threat To Obesity Leaders? ]]>premium

      
]]> https://feeds.feedblitz.com/~/972763652/0/scrip~Boehringer-Ready-To-File-Survodutide-But-At-What-Threat-To-Obesity-Leaders/https://insights.citeline.com/scrip/therapeutic-category/alimentary-metabolic/obesity/boehringer-ready-to-file-survodutide-but-at-what-threat-to-obesity-leaders-S2CFSJ4A2VDKVCMK5DPPGMYALA/
      
]]> Tue, 10 Nov 2026 14:51:32 +0000 https://insights.citeline.com/scrip/new-products/bayer-all-set-for-sunharbo-launch-as-stroke-drug-seals-fda-okay-QEJQDPLJWVFHFPP5GGRLQC6NUE/<![CDATA[Bayer All Set For Sunharbo Launch As Stroke Drug Seals FDA Okay]]>premium

      
]]> https://feeds.feedblitz.com/~/972756617/0/scrip~Bayer-All-Set-For-Sunharbo-Launch-As-Stroke-Drug-Seals-FDA-Okay/https://insights.citeline.com/scrip/new-products/bayer-all-set-for-sunharbo-launch-as-stroke-drug-seals-fda-okay-QEJQDPLJWVFHFPP5GGRLQC6NUE/
      
]]> Tue, 10 Nov 2026 12:26:45 +0000 https://insights.citeline.com/scrip/digital-technologies/ai/biobytes/rivia-adds-ai-powered-data-checks-to-clinical-trial-platform-P2G6ADRS2ZBW3CKGOGBPHJJWDY/<![CDATA[Rivia Adds AI-Powered Data Checks To Clinical Trial Platform]]>premium

      
]]> https://feeds.feedblitz.com/~/972759983/0/scrip~Rivia-Adds-AIPowered-Data-Checks-To-Clinical-Trial-Platform/https://insights.citeline.com/scrip/digital-technologies/ai/biobytes/rivia-adds-ai-powered-data-checks-to-clinical-trial-platform-P2G6ADRS2ZBW3CKGOGBPHJJWDY/
      
]]> Tue, 10 Nov 2026 13:50:50 +0000 https://insights.citeline.com/scrip/business/earnings/q3-earnings-roundup-roivant-ionis-lundbeck-6R4LHVX3EJFF5CWBCRZXJPCYNA/<![CDATA[Q3 Earnings Roundup: Roivant, Ionis, Lundbeck]]>premium

      
]]> https://feeds.feedblitz.com/~/972784913/0/scrip~Q-Earnings-Roundup-Roivant-Ionis-Lundbeck/https://insights.citeline.com/scrip/business/earnings/q3-earnings-roundup-roivant-ionis-lundbeck-6R4LHVX3EJFF5CWBCRZXJPCYNA/
      
]]> Tue, 10 Nov 2026 21:13:05 +0000 https://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-proximal-ventures-backs-ai-based-life-sciences-solutions-with-new-fund-IQ2FSYBJ5JHSVENF77PKC4VCFI/<![CDATA[Finance Watch: Proximal Ventures Backs AI-Based Life Sciences Solutions With New Fund ]]>premium

      
]]> https://feeds.feedblitz.com/~/972785753/0/scrip~Finance-Watch-Proximal-Ventures-Backs-AIBased-Life-Sciences-Solutions-With-New-Fund/https://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-proximal-ventures-backs-ai-based-life-sciences-solutions-with-new-fund-IQ2FSYBJ5JHSVENF77PKC4VCFI/
      
]]> Tue, 10 Nov 2026 21:38:01 +0000 https://insights.citeline.com/scrip/conferences/aasld-2026-regeneron-gsk-merck-look-to-bring-competition-in-mash-P2KHJHM66FFKJKTAQWLXDZBX4E/<![CDATA[AASLD 2026: Regeneron, GSK, Merck Look To Bring Competition In MASH]]>premium

      
]]> https://feeds.feedblitz.com/~/972786836/0/scrip~AASLD-Regeneron-GSK-Merck-Look-To-Bring-Competition-In-MASH/https://insights.citeline.com/scrip/conferences/aasld-2026-regeneron-gsk-merck-look-to-bring-competition-in-mash-P2KHJHM66FFKJKTAQWLXDZBX4E/
      
]]> Tue, 10 Nov 2026 22:14:43 +0000 https://insights.citeline.com/scrip/r-and-d/clinical-trials/novartiss-detailed-pelacarsen-data-leave-little-hope-for-other-lpa-lowering-drugs-TFGLCFM66VHEXGEZQ3PK7OK4DE/<![CDATA[Novartis’s Detailed Pelacarsen Data Leave Little Hope For Other Lp(a)-Lowering Drugs]]>premium

      
]]> https://feeds.feedblitz.com/~/972725339/0/scrip~Novartis%e2%80%99s-Detailed-Pelacarsen-Data-Leave-Little-Hope-For-Other-LpaLowering-Drugs/https://insights.citeline.com/scrip/r-and-d/clinical-trials/novartiss-detailed-pelacarsen-data-leave-little-hope-for-other-lpa-lowering-drugs-TFGLCFM66VHEXGEZQ3PK7OK4DE/
      
]]> Mon, 09 Nov 2026 22:41:32 +0000 https://insights.citeline.com/scrip/r-and-d/pipeline-watch/pipeline-watch-three-approvals-and-eleven-phase-iii-readouts-RGYQNWKNKNDBBDVOV7HXYDV5BQ/<![CDATA[Pipeline Watch: Three Approvals And Eleven Phase III Readouts]]>premium

      
]]> https://feeds.feedblitz.com/~/972749111/0/scrip~Pipeline-Watch-Three-Approvals-And-Eleven-Phase-III-Readouts/https://insights.citeline.com/scrip/r-and-d/pipeline-watch/pipeline-watch-three-approvals-and-eleven-phase-iii-readouts-RGYQNWKNKNDBBDVOV7HXYDV5BQ/
      
]]> Tue, 10 Nov 2026 09:41:57 +0000 https://insights.citeline.com/scrip/therapeutic-category/immunological/acr-2026-novartisabogens-mrna-t-cell-engager-shows-initial-promise-in-scleroderma-KOBJZ2V5AVG57AECMIF5AUBGWQ/<![CDATA[ACR 2026: Novartis/Abogen’s mRNA T-Cell Engager Shows Initial Promise In Scleroderma]]>premium

      
]]> https://feeds.feedblitz.com/~/972747035/0/scrip~ACR-NovartisAbogen%e2%80%99s-mRNA-TCell-Engager-Shows-Initial-Promise-In-Scleroderma/https://insights.citeline.com/scrip/therapeutic-category/immunological/acr-2026-novartisabogens-mrna-t-cell-engager-shows-initial-promise-in-scleroderma-KOBJZ2V5AVG57AECMIF5AUBGWQ/
      
]]> Tue, 10 Nov 2026 08:10:09 +0000 https://insights.citeline.com/scrip/focus-on-asia/china/astellas-employee-imprisoned-in-china-reportedly-released-next-month-T63O4JLLVFFTLAO3OBUM6D4OQ4/<![CDATA[Astellas Employee Imprisoned In China Reportedly Released Next Month]]>premium

      
]]> https://feeds.feedblitz.com/~/972745040/0/scrip~Astellas-Employee-Imprisoned-In-China-Reportedly-Released-Next-Month/https://insights.citeline.com/scrip/focus-on-asia/china/astellas-employee-imprisoned-in-china-reportedly-released-next-month-T63O4JLLVFFTLAO3OBUM6D4OQ4/
      
]]> Tue, 10 Nov 2026 07:26:13 +0000 https://insights.citeline.com/scrip/advanced-therapies/cell-therapies/cultivating-an-ipsc-ecosystem-racthera-ceo-on-japan-cell-therapy-journey-4NMXSHF4ORAXNDYQSUIMA5B76Q/<![CDATA[Cultivating An iPSC Ecosystem: RACTHERA CEO On Japan Cell Therapy Journey]]>premium

      
]]> https://feeds.feedblitz.com/~/972741755/0/scrip~Cultivating-An-iPSC-Ecosystem-RACTHERA-CEO-On-Japan-Cell-Therapy-Journey/https://insights.citeline.com/scrip/advanced-therapies/cell-therapies/cultivating-an-ipsc-ecosystem-racthera-ceo-on-japan-cell-therapy-journey-4NMXSHF4ORAXNDYQSUIMA5B76Q/
      
]]> Tue, 10 Nov 2026 05:15:12 +0000 https://insights.citeline.com/scrip/r-and-d/clinical-trials/jjs-prostate-cancer-combo-shows-promise-as-phase-iii-proceeds-GAV3XJUP4JFIZI6MC7KE7LHCXI/<![CDATA[J&J’s Prostate Cancer Combo Shows Promise, As Phase III Proceeds ]]>premium

      
]]> https://feeds.feedblitz.com/~/972693392/0/scrip~JJ%e2%80%99s-Prostate-Cancer-Combo-Shows-Promise-As-Phase-III-Proceeds/https://insights.citeline.com/scrip/r-and-d/clinical-trials/jjs-prostate-cancer-combo-shows-promise-as-phase-iii-proceeds-GAV3XJUP4JFIZI6MC7KE7LHCXI/
      
]]> Mon, 09 Nov 2026 13:30:56 +0000 https://insights.citeline.com/scrip/conferences/acr-2026-a-tale-of-three-cell-therapies-EDJDSJB2PNCGFHZEHONHNO5CUA/<![CDATA[ACR 2026: A Tale Of Three Cell Therapies ]]>premium

      
]]> https://feeds.feedblitz.com/~/972723722/0/scrip~ACR-A-Tale-Of-Three-Cell-Therapies/https://insights.citeline.com/scrip/conferences/acr-2026-a-tale-of-three-cell-therapies-EDJDSJB2PNCGFHZEHONHNO5CUA/
      
]]> Mon, 09 Nov 2026 22:07:40 +0000 https://insights.citeline.com/scrip/business/deals/argenx-buys-unnatural-products-gaining-macrocyclic-peptide-discovery-platform-QWESSUZJ5BCQZEYGIQ572KBHSE/<![CDATA[Argenx Buys Unnatural Products, Gaining Macrocyclic Peptide Discovery Platform]]>premium

      
]]> https://feeds.feedblitz.com/~/972722993/0/scrip~Argenx-Buys-Unnatural-Products-Gaining-Macrocyclic-Peptide-Discovery-Platform/https://insights.citeline.com/scrip/business/deals/argenx-buys-unnatural-products-gaining-macrocyclic-peptide-discovery-platform-QWESSUZJ5BCQZEYGIQ572KBHSE/
      
]]> Mon, 09 Nov 2026 21:54:06 +0000 https://insights.citeline.com/scrip/conferences/bio-europe/bio-europe-wise-words-from-industry-vets-levin-and-moses-DWFNQX4MZJBENF75DGBFQAQ3RU/<![CDATA[BIO-Europe: Wise Words From Industry Vets Levin And Moses]]>premium

      
]]> https://feeds.feedblitz.com/~/972708863/0/scrip~BIOEurope-Wise-Words-From-Industry-Vets-Levin-And-Moses/https://insights.citeline.com/scrip/conferences/bio-europe/bio-europe-wise-words-from-industry-vets-levin-and-moses-DWFNQX4MZJBENF75DGBFQAQ3RU/
      
]]> Mon, 09 Nov 2026 15:59:31 +0000 https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/scrips-five-must-know-things-madrigals-mash-whistleblower-lilly-sanofi-hunt-deals-7POQJZSOQBBZJIMIFA6BBVUQZU/<![CDATA[Scrip’s Five Must-Know Things: Madrigal’s MASH Whistleblower, Lilly, Sanofi Hunt Deals ]]>free

      
]]> https://feeds.feedblitz.com/~/972662603/0/scrip~Scrip%e2%80%99s-Five-MustKnow-Things-Madrigal%e2%80%99s-MASH-Whistleblower-Lilly-Sanofi-Hunt-Deals/https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/scrips-five-must-know-things-madrigals-mash-whistleblower-lilly-sanofi-hunt-deals-7POQJZSOQBBZJIMIFA6BBVUQZU/
      
]]> Mon, 09 Nov 2026 02:06:53 +0000